Latest News
Conference Coverage
Immunotherapies under investigation in newly diagnosed B-ALL
SAN FRANCISCO – Researchers are testing blinatumomab and inotuzumab ozogamicin as first-line treatment in B-cell acute lymphoblastic leukemia.
News
Novel research aims to improve ED care in sickle cell disease
Researchers are testing the best acute pain management strategies to respond to a vasoocclusive crisis.
News
Clip closure reduced bleeding after large lesion resection
Delayed bleeding after resection of large nonpedunculated polyps was significantly reduced after clip closure.
News
Medical boards change or consider amending mental health-related licensing questions
Florida’s current medical licensing application may deter physicians from seeking care if they develop conditions such as depression, says Delicia...
FDA/CDC
FDA adds diabetic kidney disease, heart failure indications to canagliflozin
This marks the first time in 20 years that a drug has been indicated for diabetic kidney disease treatment, according to the manufacturer.
Conference Coverage
Immunotherapy duo extends survival in first line for advanced NSCLC
BARCELONA – Nivolumab and low-dose ipilimumab improved survival of patients with untreated advanced non–small cell lung cancer regardless of PD-L1...
Conference Coverage
Cardiotoxicity after checkpoint inhibitor treatment seen early, linked to elevated biomarkers
PHILADELPHIA – The findings support monitoring of cardiac biomarkers in the initial phase of checkpoint inhibitor treatment to identify patients...
Conference Coverage
Adjuvant radiotherapy no better than salvage post prostatectomy
BARCELONA – Men who underwent prostatectomy fared just as well with observation and salvage radiotherapy as with adjuvant radiotherapy.
Conference Coverage
Patient-reported outcomes are here to stay
WASHINGTON – Despite growing interest in incorporating patient-reported outcomes into physician and hospital performance measures, officials are...
Conference Coverage
Cancer drug prices higher in U.S. than Europe; don’t correlate with clinical benefit
BARCELONA – Cancer drug prices are significantly higher in the United states than in Europe, and they don’t correlate with clinical benefit in...